David R Brennan - Net Worth and Insider Trading

David R Brennan Net Worth

The estimated net worth of David R Brennan is at least $2 Million dollars as of 2024-04-20. David R Brennan is the Director of Insmed Inc and owns about 80,876 shares of Insmed Inc (INSM) stock worth over $2 Million. Details can be seen in David R Brennan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David R Brennan has not made any transactions after 2021-11-01 and currently still holds the listed stock(s).

Transaction Summary of David R Brennan

To

David R Brennan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David R Brennan owns 3 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Insmed Inc (INSM) , and Innocoll Holdings PLC (INNL) .

Click here to see the complete history of David R Brennan’s form 4 insider trades.

Insider Ownership Summary of David R Brennan

Ticker Comapny Transaction Date Type of Owner
ALXN Alexion Pharmaceuticals Inc 2020-05-14 director
INSM Insmed Inc 2021-11-01 director
INNL Innocoll Holdings PLC 2017-07-24 director

David R Brennan Latest Holdings Summary

David R Brennan currently owns a total of 1 stock. David R Brennan owns 80,876 shares of Insmed Inc (INSM) as of November 1, 2021, with a value of $2 Million.

Latest Holdings of David R Brennan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INSM Insmed Inc 2021-11-01 80,876 24.32 1,966,904

Holding Weightings of David R Brennan


David R Brennan Form 4 Trading Tracker

According to the SEC Form 4 filings, David R Brennan has made a total of 1 transactions in Insmed Inc (INSM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Insmed Inc is the acquisition of 10,000 shares on November 1, 2021, which cost David R Brennan around $301,500.

Insider Trading History of David R Brennan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David R Brennan Trading Performance

GuruFocus tracks the stock performance after each of David R Brennan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David R Brennan is -23.64%. GuruFocus also compares David R Brennan's trading performance to market benchmark return within the same time period. The performance of stocks bought by David R Brennan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David R Brennan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David R Brennan

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.04 -23.64 -29.24 -43.64 -10.29
Relative Return to S&P 500(%) -11.86 -22.18 -18.8 -27.22 -6.13

David R Brennan Ownership Network

Ownership Network List of David R Brennan

No Data

Ownership Network Relation of David R Brennan


David R Brennan Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Who are the key executives at Alexion Pharmaceuticals Inc?

David R Brennan is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .

Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

David R Brennan Mailing Address

Above is the net worth, insider trading, and ownership report for David R Brennan. You might contact David R Brennan via mailing address: C/o Insmed Incorporated, 10 Finderne Avenue, Bridgewater Nj 08807.

Discussions on David R Brennan

No discussions yet.